Apheresis Market to Surpass Valuation of USD 6,882.1 Billion By 2032: Astute Analytica
GlobeNewswire
The global apheresis market is thriving driven by rising chronic diseases, efficient blood collection, and growing demand for blood..
The global apheresis market is thriving driven by rising chronic diseases, efficient blood collection, and growing demand for blood..
· *10-year efficacy data highlight OCREVUS’ impact on preventing disability progression and maintaining mobility in both..
· *Phase III OCARINA II trial met primary and secondary endpoints
*
· *OCREVUS twice a year, 10-minute injection..